0.00Open0.05Pre Close0 Volume30 Open Interest100.00Strike Price0.00Turnover541.48%IV28.50%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0164Delta0.0046Gamma1557.20Leverage Ratio-1.0210Theta0.0000Rho25.50Eff Leverage0.0007Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet